Aktuality
Ipsen pursues its development in the United States with the opening of its new commercial headquarters in New Jersey (NJ)
Středa, 25 Duben 2012 00:00
Ipsen’s partner, Inspiration Biopharmaceuticals, announces US filing of Biologics License Application (BLA) for IB1001, a recombinant factor IX product for the treatment of hemophilia B
Úterý, 17 Duben 2012 00:00
The 20 th Colloque Médecine et Recherche of the Fondation Ipsen in the Neurosciences series: "Programmed cells: from basic neuroscience to therapy"
Úterý, 03 Duben 2012 00:00
